The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of patients with operable renal cell carcinoma from the German translational cancer research consortium (DKTK) network.
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Onkowissen; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Serono; Pfizer
 
Christian Thomas
Stock and Other Ownership Interests - Orion Biotechnology
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - BMSi; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Maria De Santis
Honoraria - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Exelixis/Ipsen; Ferring; Gilead Sciences; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen
Consulting or Advisory Role - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Ferring; Gilead Sciences; GlaxoSmithKline; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Orion Health; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Roche; Roche/Genentech; Sanofi
 
Christian Gratzke
No Relationships to Disclose
 
Felix Chun
No Relationships to Disclose
 
Rene Mager
No Relationships to Disclose
 
Margitta Retz
No Relationships to Disclose
 
Gunhild Von Amsberg
Consulting or Advisory Role - Astellas Amgen BioPharama; AstraZeneca; Bayer; BMS GmbH & Co. KG; IPSEN,; Janssen; Merck; MSD; Pfizer; Roche Pharma AG
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN,; Merck Serono; MSD; Pfizer
Research Funding - AvenCell (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); IPSEN, (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IPSEN,; Janssen; Pfizer/EMD Serono; Roche
 
Philipp Ivanyi
Stock and Other Ownership Interests - BB Biotech Ventures
Honoraria - AIMM Therapeutics; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
Other Relationship - Merck Serono; Pfizer
 
Bolenz Christian
Honoraria - AstraZeneca; Janssen-Cilag; Medac; Takeda
Research Funding - Erbe Elektromedizin (Inst)
 
Hubert Kübler
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen
 
Svenja Hahn
No Relationships to Disclose
 
Ian Erhard
No Relationships to Disclose
 
Bastian Reiter
No Relationships to Disclose
 
Martin Lablans
No Relationships to Disclose
 
Janne Vehreschild
No Relationships to Disclose
 
Daniel Brucker
No Relationships to Disclose
 
Daniel Maier
No Relationships to Disclose